These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 31165977)

  • 21. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli.
    Hozzari A; Behzadi P; Kerishchi Khiabani P; Sholeh M; Sabokroo N
    J Appl Genet; 2020 May; 61(2):265-273. PubMed ID: 31950434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel chaperone-effector-immunity system identified in uropathogenic
    Casiano González A; Pacheco Villanueva A; Castro-Alarcón N; Méndez J; Oropeza R; Martínez-Santos VI
    PeerJ; 2024; 12():e17336. PubMed ID: 38784397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of acute urinary tract infections caused by uropathogenic
    Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
    Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective anti-adhesives of uropathogenic Escherichia coli.
    Ribić R; Meštrović T; Neuberg M; Kozina G
    Acta Pharm; 2018 Mar; 68(1):1-18. PubMed ID: 29453908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC.
    Gupta S; Kumar P; Rathi B; Verma V; Dhanda RS; Devi P; Yadav M
    Sci Rep; 2021 Sep; 11(1):17801. PubMed ID: 34493749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. sRNA-Mediated Regulation of P-Fimbriae Phase Variation in Uropathogenic Escherichia coli.
    Khandige S; Kronborg T; Uhlin BE; Møller-Jensen J
    PLoS Pathog; 2015 Aug; 11(8):e1005109. PubMed ID: 26291711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.
    Owrangi B; Masters N; Kuballa A; O'Dea C; Vollmerhausen TL; Katouli M
    Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):833-839. PubMed ID: 29340897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
    Guiton PS; Cusumano CK; Kline KA; Dodson KW; Han Z; Janetka JW; Henderson JP; Caparon MG; Hultgren SJ
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4738-45. PubMed ID: 22733070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract.
    Vigil PD; Stapleton AE; Johnson JR; Hooton TM; Hodges AP; He Y; Mobley HL
    mBio; 2011; 2(3):e00066-11. PubMed ID: 21540363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOLECULAR CHARACTERIZATION OF VIRULENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF UROPATHOGENIC ESCHERICHIA COLI FROM PATIENTS IN A TERTIARY HOSPITAL, SOUTHERN THAILAND.
    Themphachanal M; Kongpheng S; Rattanachuay P; Khianngam S; Singkhamanan K; Sukhumungoon P
    Southeast Asian J Trop Med Public Health; 2015 Nov; 46(6):1021-30. PubMed ID: 26867360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uropathogenic
    Alfuraiji N; Al-Hamami A; Ibrahim M; Rajab HK; Hussain BW
    J Med Life; 2022 May; 15(5):650-654. PubMed ID: 35815089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The RyfA small RNA regulates oxidative and osmotic stress responses and virulence in uropathogenic Escherichia coli.
    Bessaiah H; Pokharel P; Loucif H; Kulbay M; Sasseville C; Habouria H; Houle S; Bernier J; Massé É; Van Grevenynghe J; Dozois CM
    PLoS Pathog; 2021 May; 17(5):e1009617. PubMed ID: 34043736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biogenesis and adhesion of type 1 and P pili.
    Lillington J; Geibel S; Waksman G
    Biochim Biophys Acta; 2014 Sep; 1840(9):2783-93. PubMed ID: 24797039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virulence and Fitness Determinants of Uropathogenic Escherichia coli.
    Subashchandrabose S; Mobley HLT
    Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenomics of uropathogenic Escherichia coli.
    Agarwal J; Srivastava S; Singh M
    Indian J Med Microbiol; 2012; 30(2):141-9. PubMed ID: 22664427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross Talk between MarR-Like Transcription Factors Coordinates the Regulation of Motility in Uropathogenic Escherichia coli.
    Luterbach CL; Mobley HLT
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?
    Scharf B; Schmidt TJ; Rabbani S; Stork C; Dobrindt U; Sendker J; Ernst B; Hensel A
    J Ethnopharmacol; 2020 Jul; 257():112889. PubMed ID: 32311481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073.
    Allsopp LP; Beloin C; Ulett GC; Valle J; Totsika M; Sherlock O; Ghigo JM; Schembri MA
    Infect Immun; 2012 Jan; 80(1):321-32. PubMed ID: 21930758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation.
    Ulett GC; Mabbett AN; Fung KC; Webb RI; Schembri MA
    Microbiology (Reading); 2007 Jul; 153(Pt 7):2321-2331. PubMed ID: 17600076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation.
    Ong CL; Ulett GC; Mabbett AN; Beatson SA; Webb RI; Monaghan W; Nimmo GR; Looke DF; McEwan AG; Schembri MA
    J Bacteriol; 2008 Feb; 190(3):1054-63. PubMed ID: 18055599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.